Report #2833661

Received Mar 28, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: IA
Recovered: Unknown
Vaccinated: Feb 24, 2025
Onset: —
Days to onset: —
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MMR	MEASLES + MUMPS + RUBELLA (MMR II)	MERCK & CO. INC.	1	Y013131	—
MMR	MEASLES + MUMPS + RUBELLA (MMR II)	MERCK & CO. INC.	UNK	—	—

Symptoms (1)

Inflammation

Symptom narrative

inflammation; This spontaneous report was received from a pharmacist and refers to a male patient of unknown age. The patient's medical history, concurrent conditions were, and concomitant therapies were not reported. On 24-Feb-2025, the patient was vaccinated for prophylaxis with a dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), Solution for injection (lot #Y013131, expiration date: 30-Jul-2026), 0.5 mL/ series) reconstituted with sterile diluent (BAXTER STERILE DILUENT). On an unspecified date in 2025, the patient probably experienced inflammation as the pharmacist received an order for methylprednisolone (MEDROL DOSE PACK). At the reporting time, the outcome of inflammation was unknown. The causal relationship between the event of inflammation and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) sterile diluent (BAXTER STERILE DILUENT) was not reported.